Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-15 11:35 am Unchanged | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital LLC | 6,995,861 8.4% | 0 (Unchanged) | View |
| 2024-02-15 09:15 am Unchanged | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital LLC | 6,995,861 8.4% | 0 (Unchanged) | View |
| 2024-02-14 8:02 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital LLC | 6,995,861 8.4% | 811,000 (+13.11%) | View |
| 2024-02-13 4:58 pm Sale | 13G | ATEA PHARMACEUTICALS INC AVIR | VANGUARD GROUP INC | 4,599,710 5.51% | -1,489,812 (-24.47%) | View |
| 2024-02-13 4:30 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | Sommadossi Jean-Pierre | 8,162,914 9.6% | 688,032 (+9.20%) | View |
| 2024-02-09 08:35 am Sale | 13G | ATEA PHARMACEUTICALS INC AVIR | FMR LLC | 5,350,659 6.412% | -1,723,628 (-24.36%) | View |
| 2024-02-07 09:25 am Unchanged | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners L.P. | 5,602,079 6.7% | 0 (Unchanged) | View |
| 2024-02-07 09:14 am Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners L.P. | 5,602,079 6.7% | 1,418,434 (+33.90%) | View |
| 2024-01-24 09:46 am Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | BlackRock Inc. BLK | 9,443,887 11.3% | 605,872 (+6.86%) | View |
| 2023-11-28 06:00 am Purchase | 13D | ATEA PHARMACEUTICALS INC AVIR | TANG CAPITAL PARTNERS LP | 4,033,463 4.8% | 1,007,008 (+33.27%) | View |
| 2023-11-07 3:33 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | BlackRock Inc. BLK | 8,838,015 10.6% | 804,443 (+10.01%) | View |
| 2023-10-02 11:45 am Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners L.P. | 4,183,645 5% | 4,183,645 (New Position) | View |
| 2023-09-11 08:23 am Sale | 13G | ATEA PHARMACEUTICALS INC AVIR | FMR LLC | 7,074,287 8.482% | -4,663,122 (-39.73%) | View |
| 2023-05-22 09:00 am Purchase | 13D | ATEA PHARMACEUTICALS INC AVIR | TANG CAPITAL PARTNERS LP | 3,026,455 3.6% | 3,026,455 (New Position) | View |
| 2023-02-10 4:15 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | Sommadossi Jean-Pierre | 7,474,882 8.8% | 374,883 (+5.28%) | View |
| 2023-02-10 1:37 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital LLC | 6,184,861 7.4% | 808,727 (+15.04%) | View |
| 2023-02-09 11:07 am Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | VANGUARD GROUP INC | 6,089,522 7.31% | 307,640 (+5.32%) | View |
| 2023-02-09 08:23 am Sale | 13G | ATEA PHARMACEUTICALS INC AVIR | FMR LLC | 11,737,409 14.092% | -728,000 (-5.84%) | View |
| 2023-01-24 1:56 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | BlackRock Inc. BLK | 8,033,572 9.6% | 2,252,375 (+38.96%) | View |
| 2022-02-16 4:00 pm Sale | 13G | ATEA PHARMACEUTICALS INC AVIR | Morningside Venture Investments Ltd | 0 0% | -6,634,956 (Position Closed) | View |